Malaysia enforces medicine pricing laws, Skechers seals a record buyout deal, and Asian currencies strengthen as global markets react to the dollar’s decline.

Malaysia News
Malaysia has rolled out a landmark Medicine Price Transparency Mechanism, requiring all private healthcare providers and pharmacies to display drug prices. Effective May 1, the move aims to curb rising medical costs and aligns with WHO’s global transparency calls. Experts stress that broader reforms are needed to ensure fair wages for general practitioners and hold pharmaceutical firms accountable.

International News
Skechers has announced a US$9.42 billion buyout deal with 3G Capital—the largest in the footwear industry’s history. Amid tariff pressures and shifting consumer trends, Skechers aims to recalibrate outside the public market spotlight while maintaining its leadership team.

Asia News
Asian currencies gained traction following a dip in the US dollar. The Malaysian ringgit marked its fifth straight day of gains, with Taiwan’s dollar and the yen also strengthening. However, analysts caution that central banks are prepared to intervene if needed. Investors now await the Federal Reserve’s decision as trade war uncertainties persist.

For more in-depth coverage, subscribe at agn.alps-holdings.com and stay updated with AGN.